Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Alphapharm Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (849)
Cancellation by sponsor (780)
Prescription medicine registration (54)
Cancellation or suspension (48)
Australian Public Assessment Report (AusPAR) (3)
Designation or determination (3)
Prescription medicine decision summary (2)
Section 14, TGO91 consent (1)

Date

2024 (22)
2023 (84)
2022 (230)
2021 (265)
2020 (113)
2019 (35)
2018 (66)
2017 (364)
2016 (34)
2015 (22)
2014 (48)
2013 (40)
2012 (61)
2011 (28)
2010 (46)
2009 (25)
2008 (10)
2007 (28)
2006 (6)
2005 (17)
2004 (15)
2003 (33)
2002 (15)
2001 (4)
2000 (14)
1999 (9)
1998 (8)
1997 (11)
1996 (10)
1995 (7)
1994 (6)
1993 (12)
1992 (11)
1991 (41)

Results for "[search-keyword]"

Search

Sponsor content

1740 result(s) found, displaying 891 to 900

CIAXONE 250 ciprofloxacin 250mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 May 2018

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
CIAXONE 500 ciprofloxacin 500mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 May 2018

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
CIAXONE 750 ciprofloxacin 750mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 May 2018

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
DIZOLE 50 fluconazole 50mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

28 May 2018

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
DIZOLE 100 fluconazole 100mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

28 May 2018

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
DIZOLE 150 fluconazole 150mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

28 May 2018

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
CELAXIB celecoxib 200 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

28 May 2018

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
CELAXIB celecoxib 100 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

28 May 2018

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
RANI 2 ranitidine 150mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 May 2018

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
RANI 2 ranitidine 150mg (as hydrochloride) tablet bottle Cancelled under Section 30(1)(c) of the Act

28 May 2018

Cancellation by sponsor

Requested by Alphapharm Pty Ltd

Pages

First page
Previous page
…
Page 86
Page 87
Page 88
Page 89
Current page 90
Page 91
Page 92
Page 93
Page 94
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.